Search

Your search keyword '"Cecchetto M."' showing total 182 results

Search Constraints

Start Over You searched for: Author "Cecchetto M." Remove constraint Author: "Cecchetto M."
182 results on '"Cecchetto M."'

Search Results

1. The n_TOF NEAR Station Commissioning and first physics case

2. The CERN n TOF NEAR station for astrophysics- and application-related neutron activation measurements

Catalog

Books, media, physical & digital resources

3. Design development and implementation of an irradiation station at the neutron time-of-flight facility at CERN

5. The development of stochastic based transport models to predict the advection and diffusion of bed-load sediment

6. EUROfusion contributions to ITER nuclear operation.

7. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

8. Fusion Neutron-Induced Soft Errors During Long Pulse D-D Plasma Discharges in the WEST Tokamak

9. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

10. The n_TOF NEAR Station Commissioning and first physics case

11. Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL

12. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study

13. The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort

14. The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort

15. Evaluation of HIV transmission clusters among natives and foreigners living in Italy

16. Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress?

17. Virological response and retention in care according to time of starting ART in Italy: Data from the Icona Foundation Study cohort

18. Evaluation of HIV transmission clusters among natives and foreigners living in Italy

19. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

20. Virological response and retention in care according to time of starting ART in Italy: data from the Icona Foundation Study cohort

21. Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

22. Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study

23. Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL

24. Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort

25. Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-2014

26. First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison

27. Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection?

28. Biodiversity, community structure and ecosystem function on kelp and wood falls in the Norwegian deep sea

30. Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study

31. Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline viro-immunological status and outcome in patients under first-line ART

34. Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort

35. Switching to dual/monotherapy determines an increase in CD8+ in HIV-infected individuals: An observational cohort study

38. Direct Ionization Impact on Accelerator Mixed-Field Soft Error Rate

40. The Pion Single Event Effect Resonance and its Impact in an Accelerator Environment

42. Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL

43. Drop in CD4+ counts below 200 cells/µL after reaching (or starting from) values higher than 350 cells/µL in HIV‐infected patients with virological suppression

44. Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL

45. Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort

46. Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting

47. Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV

48. Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort

49. Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort

50. Distributional records of Antarctic Porifera from samples stored at the Italian National Antarctic Museum (MNA), with an update of the checklist for the Terra Nova Bay area (Ross Sea)